Fusion Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FUSN and buy or sell other stocks, ETFs, and their options commission-free!About FUSN
Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease.
CEOJohn Valliant, PhD
CEOJohn Valliant, PhD
Employees—
Employees—
HeadquartersHamilton, Ontario
HeadquartersHamilton, Ontario
Founded2014
Founded2014
Employees—
Employees—
FUSN Key Statistics
Market cap1.83B
Market cap1.83B
Price-Earnings ratio-15.21
Price-Earnings ratio-15.21
Dividend yield—
Dividend yield—
Average volume608.92K
Average volume608.92K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$21.60
52 Week high$21.60
52 Week low$2.31
52 Week low$2.31
Stock Snapshot
As of today, Fusion Pharmaceuticals(FUSN) shares are valued at $21.55. The company's market cap stands at 1.83B, with a P/E ratio of -15.21.
On 2025-11-30, Fusion Pharmaceuticals(FUSN) stock opened at —, reached a high of —, and a low of —.
Fusion Pharmaceuticals(FUSN) shares are trading with a volume of 0, against a daily average of 608.92K.
In the last year, Fusion Pharmaceuticals(FUSN) shares hit a 52-week high of $21.60 and a 52-week low of $2.31.
In the last year, Fusion Pharmaceuticals(FUSN) shares hit a 52-week high of $21.60 and a 52-week low of $2.31.
People also own
Based on the portfolios of people who own FUSN. This list is generated using Robinhood data, and it’s not a recommendation.